MEXICO – The Novartis pharmaceutical company reported that authorization was obtained from health officials to sell a drug to combat metastatic breast cancer (that extends to other parts of the body), which would allow a survival of up to five years.
In a press conference the general director of Novartis Oncology, Miguel Gallero, and medical specialists, highlighted the benefits of this drug that obtained the sanitary registry in November and will be available in the first third of 2018.
Gallero informed that Novartis invested nine billion dollars in 2016, worldwide, to promote the research of various molecules to continue the development of innovative medicines, such as the one called Ribociclib.
He added that precisely with the support of these innovative medicines, treatments are offered that give hope to patients to extend their life with quality, even to incorporate them into their daily tasks.
He indicated that 60% to 80 % of metastatic cancer in Mexico is diagnosed in locally advanced stages, however, with the application of new treatments, 81% of patients in stage four, which is among the most advanced, achieves five-year survival.
Meanwhile, the medical director of Novartis Oncology, Guillermina Muñoz, said that the treatments that this international laboratory has developed have revolutionized the context of patients with metastatic breast cancer in the world.
She highlighted that by doing research on the molecule that gives rise to Ribociclib, the increase, almost double, of progression-free survival, which allows a better quality of life, was demonstrated.
She explained that after two years of treatment, the combination of Ribociclib plus Letrozole increased the percentage of progression-free survival to 54.7%, compared with 35.9% in patients treated only with Letrozole.
The psychologist Alejandra Platas, of the Doctors and Researchers Foundation in the Fight against Breast Cancer (MILC), pointed out that 50 percent of the cases of advanced cancer in Mexico do not receive treatment when they face chronic pain, reason why she considered that it requires more prevention actions.
more recommended stories
Amidst pandemic, Chichén Itzá is the second most visited archaeological site in Mexico
In the last four months of.
Maya Train construction causes partial closure of the Merida-Cancun highway
For tens of kilometers, vehicles must.
Party with over 50 people shut down by police in Kanasín, Yuc.
The party was held on the.
Archaeological sites in Yucatan operating during Covid-19 pandemic
After the first coronavirus outbreaks, the.
Yucatan man dies after being involved in two traffic accidents on the same day
First, he crashed in the morning,.
Mahahual businessmen want to acquire COVID-19 vaccines
Local businessmen assure that this would.
3 bars in Mérida are closed for failing to comply with sanitary measures
The State Government closed a restaurant.
State government provides incentives to encourage henequen production
In support of Yucatecan farmers dedicated.
Clandestine cockfight suspended in Abalá, Yucatan
A cockfight, allegedly authorized by the.
More than 65 million shots of the Covid vaccine have been administered throughout the world
The biggest vaccination campaign in history.